173 related articles for article (PubMed ID: 14680377)
1. Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes.
Patterson TJ; Ngo M; Aronov PA; Reznikova TV; Green PG; Rice RH
Chem Res Toxicol; 2003 Dec; 16(12):1624-31. PubMed ID: 14680377
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: II. Enzymatic formation of arsenylated products susceptible for reduction to arsenite by thiols.
Gregus Z; Roos G; Geerlings P; Németi B
Toxicol Sci; 2009 Aug; 110(2):282-92. PubMed ID: 19478237
[TBL] [Abstract][Full Text] [Related]
3. Arsenolysis and thiol-dependent arsenate reduction.
Thomas DJ
Toxicol Sci; 2010 Oct; 117(2):249-52. PubMed ID: 20660472
[TBL] [Abstract][Full Text] [Related]
4. Difference in uptake and toxicity of trivalent and pentavalent inorganic arsenic in rat heart microvessel endothelial cells.
Hirano S; Cui X; Li S; Kanno S; Kobayashi Y; Hayakawa T; Shraim A
Arch Toxicol; 2003 Jun; 77(6):305-12. PubMed ID: 12799770
[TBL] [Abstract][Full Text] [Related]
5. One-third-the-sites transition-state inhibitors for purine nucleoside phosphorylase.
Miles RW; Tyler PC; Furneaux RH; Bagdassarian CK; Schramm VL
Biochemistry; 1998 Jun; 37(24):8615-21. PubMed ID: 9628722
[TBL] [Abstract][Full Text] [Related]
6. Arsenite and insulin exhibit opposing effects on epidermal growth factor receptor and keratinocyte proliferative potential.
Patterson TJ; Rice RH
Toxicol Appl Pharmacol; 2007 May; 221(1):119-28. PubMed ID: 17400267
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-dependent reduction of arsenate in human erythrocytes--a process independent of purine nucleoside phosphorylase.
Németi B; Gregus Z
Toxicol Sci; 2004 Dec; 82(2):419-28. PubMed ID: 15470234
[TBL] [Abstract][Full Text] [Related]
8. Gene expression patterns as potential molecular biomarkers for malignant transformation in human keratinocytes treated with MNNG, arsenic, or a metal mixture.
Bae DS; Handa RJ; Yang RS; Campain JA
Toxicol Sci; 2003 Jul; 74(1):32-42. PubMed ID: 12773770
[TBL] [Abstract][Full Text] [Related]
9. Forced uptake of trivalent and pentavalent methylated and inorganic arsenic and its cyto-/genotoxicity in fibroblasts and hepatoma cells.
Dopp E; Hartmann LM; von Recklinghausen U; Florea AM; Rabieh S; Zimmermann U; Shokouhi B; Yadav S; Hirner AV; Rettenmeier AW
Toxicol Sci; 2005 Sep; 87(1):46-56. PubMed ID: 15947026
[TBL] [Abstract][Full Text] [Related]
10. Environmental biochemistry of arsenic.
Tamaki S; Frankenberger WT
Rev Environ Contam Toxicol; 1992; 124():79-110. PubMed ID: 1732996
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake and metabolic reduction of pentavalent to trivalent arsenic as determinants of cytotoxicity and morphological transformation.
Bertolero F; Pozzi G; Sabbioni E; Saffiotti U
Carcinogenesis; 1987 Jun; 8(6):803-8. PubMed ID: 3608077
[TBL] [Abstract][Full Text] [Related]
12. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
[TBL] [Abstract][Full Text] [Related]
13. [Tight binding transition state analogues of purine nucleoside phosphorylase--meaning, design and properties].
Lewandowicz A
Postepy Biochem; 2004; 50(3):218-27. PubMed ID: 15822751
[No Abstract] [Full Text] [Related]
14. Arsenic-induced dyslipidemia in male albino rats: comparison between trivalent and pentavalent inorganic arsenic in drinking water.
Afolabi OK; Wusu AD; Ogunrinola OO; Abam EO; Babayemi DO; Dosumu OA; Onunkwor OB; Balogun EA; Odukoya OO; Ademuyiwa O
BMC Pharmacol Toxicol; 2015 Jun; 16():15. PubMed ID: 26044777
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and metabolism of subcytotoxic inorganic arsenic in human renal proximal tubule epithelial cells (HK-2).
Peraza MA; Carter DE; Gandolfi AJ
Cell Biol Toxicol; 2003 Aug; 19(4):253-64. PubMed ID: 14686617
[TBL] [Abstract][Full Text] [Related]
16. An integrated pharmacokinetic and pharmacodynamic study of arsenite action. 1. Heme oxygenase induction in rats.
Kitchin KT; Del Razo LM; Brown JL; Anderson WL; Kenyon EM
Teratog Carcinog Mutagen; 1999; 19(6):385-402. PubMed ID: 10587409
[TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity of inorganic arsenic in whole embryo: culture oxidation state, dose, time, and gestational age dependence.
Tabocova S; Hunter ES; Gladen BC
Toxicol Appl Pharmacol; 1996 Jun; 138(2):298-307. PubMed ID: 8658531
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes.
Vega L; Styblo M; Patterson R; Cullen W; Wang C; Germolec D
Toxicol Appl Pharmacol; 2001 May; 172(3):225-32. PubMed ID: 11312651
[TBL] [Abstract][Full Text] [Related]
19. Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC
J Med Chem; 2003 Jul; 46(15):3412-23. PubMed ID: 12852771
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of thiol-supported arsenate reduction mediated by phosphorolytic-arsenolytic enzymes: I. The role of arsenolysis.
Németi B; Gregus Z
Toxicol Sci; 2009 Aug; 110(2):270-81. PubMed ID: 19474219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
